Tenders of Aok Plus The Health Fund For Saxony And

Tenders of Aok Plus The Health Fund For Saxony And

AOK PLUS The Health Fund For Saxony And Tender

Corrigendum : Closing Date Modified
Germany
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb W In the way of a so-called open-house model To the active ingredient Epoetin Zeta (recombinant Humanes Erythropoetin')
Closing Date31 May 2025
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Others
Germany
To the tender 'freital - elevator renovation'
Closing Date4 Dec 2024
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Others
Germany
In the context of a so-called open-house model To diversity X-ray contrast media (atc-code According to Who: V08)'
Closing Date31 Mar 2025
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Others
Germany
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb V In the way of a so-called open-house model To the active ingredient Tamsulosin/dutasterid (atc-code Who: G04ca52)'
Closing Date31 May 2025
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Germany
To the tender 'conclusion of non-exclusive AM discount agreement. According to Section 130a Paragraph 8 SGB V by way of a so-called open-house model for the active ingredient permethrin in the dosage form cream (atc code according to Who: P03ac04)'
Closing Date31 Oct 2025
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Others
Germany
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb W In the way of a so-called open-house model To the active ingredient Oxycodon/naloxon (atc-code After Who: N02aa55')
Closing Date31 Mar 2025
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Corrigendum : Closing Date Modified
Germany
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb W In the way of a so-called open-house model To the active ingredient Bimatoprost (atc-code After Who: S01ee03')
Closing Date30 Jun 2025
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Healthcare and Medicine
Germany
For the tender 'conclusion of non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 SGB V by means of an open-house model for the active ingredient tolvaptan (ATC code: G04BX21)'
Closing Date31 Aug 2026
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Healthcare and Medicine
Germany
For the tender 'conclusion of non-exclusive drug discount agreements according to Section 130a Paragraph 8 SGB V by way of a so-called Oh model for Ws Infliximab (atc code according to Who: L04ab02), which is used subcutaneously. Applicants Are Approved'
Closing Date31 Dec 2024
Tender AmountRefer Documents 

AOK PLUS The Health Fund For Saxony And Tender

Others
Germany
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb V In the way of a so-called open-house model To the active substance fusidic acid/betamethason (atc-code After Who: D07cc01)'
Closing Date31 Jul 2025
Tender AmountRefer Documents 
1-10 of 41 active Tenders